FDA Faces Pressure Over Mifepristone Sales
Senator Bill Cassidy leads probe into prescriptions exceeding FDA-approved 10-week limit.
Letters sent to Danco Laboratories, GenBioPro, and Evita Solutions for compliance data and prescriber audits.
FDA conducting safety study on mifepristone prescribing standards.
Report indicates 1.1 million U.S. abortions in 2025, 26% growth in mail-order drug abortions.
Conservatives claim trends undermine state protections.
5 hours ago